Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members,

We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025).

A new section, 3.3 – Pharmacy Technician Verification Guidance to Organisations, has been added to support the development and safe implementation of pharmacy technician involvement in systemic anti-cancer therapy (SACT) verification at Level 2a.

Key highlights of this new guidance include:

  • Organisations are encouraged to consider their local governance frameworks when defining the responsibilities of pharmacy technicians in SACT verification (see also Section 3.1).
  • Minimum recommended criteria for technicians undertaking Level 2a verification:
    • Band 5 or 6 (or equivalent)
    • At least two years of cancer-specific experience
    • ACT (Accuracy Checking Technician) qualification
    • Ongoing post-qualification training (e.g. Level 4 Enhanced Practice Programme or Diploma in Clinical Pharmacy Services and Therapeutics)
  • A phased and competency-based approach to scope:
    • Technicians may be approved to verify either individual SACT items (e.g. zoledronic acid) or named items within specific disease areas (e.g. breast cancer: zoledronic acid, pamidronate, denosumab, trastuzumab SC only)
    • Scope may be expanded based on additional training, log completion, and local governance approval

This addition aims to enhance clarity and consistency across the UK, while supporting the safe development of pharmacy technician roles in cancer services.

With thanks to the task group who reviewed and contributed to this update, including:

  • Netty Cracknell – Principal Pharmacist – Operations, GenesisCare UK
  • Mollie Pelingu – Pharmacy Technician, The Royal Marsden NHS Foundation Trust
  • Joseph Williams – Pharmacist, The Christie NHS Foundation Trust
  • Emma Williams – Pharmacy Technician, Velindre University NHS Trust
  • Claire Kennedy – Pharmacy Technician, Oxford University Hospitals NHS Foundation Trust
  • Melanie Lowe – Chief Clinical Pharmacy Technician, The Christie NHS Foundation Trust

The updated Standard is available via this link: https://www.bopa.org.uk/resources/bopa-standards-for-clinical-pharmacy-verification-of-cancer-medicine-prescriptions/

We encourage all members to review the updated standards document and consider how these changes may be applied within your organisation.

Best regards,

BOPA

Latest News

By BOPA Research Subcommittee on 2nd December 2025

AI in Oncology Survey

The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…

Read article
By BOPA Research Sub Committee on 2nd December 2025

Project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services

Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…

Read article
By BOPA on 28th November 2025

Pharmacists’ Essential Guide to Haematology Course – 16th and 17th March 2026 at UCLH

Back again by Popular Demand – SAVE THE DATE   Pharmacist Essential Guide to Haematology Delivered by UCLH Cancer Academy 16th and 17th March 2026 @ UCLH Education centre   Are you…

Read article
By BOPA E&T Subcommittee on 18th November 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration OPENS soon!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article